Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

BBIO holding history

BridgeBio Pharma, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BBIO overviewAll 13F holders of BBIOFull Q2 2026 holdings

Shares (Q2 2026)
3,633,007
Value
$270.6M
% of portfolio
0.2%
Quarters held
21
Since Q1 2021
Holdings of BBIO by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,633,007$270.6M0.2%+1,087,521+42.7%AddedHolders
Q1 20262,545,486$189.0M0.1%+331,455+15.0%AddedHolders
Q4 20252,214,031$169.4M0.1%−38,731−1.7%ReducedHolders
Q3 20252,252,762$117.0M0.1%+171,509+8.2%AddedHolders
Q2 20252,081,253$89.9M0.1%+1,998,104+2,403.0%AddedHolders
Q1 202583,149$2.87M<0.1%+83,149NewHolders
Q4 20240$00.0%−80,746−100.0%Sold outHolders
Q3 202480,746$2.06M<0.1%−143,382−64.0%ReducedHolders
Q2 2024224,128$5.68M<0.1%−193,760−46.4%ReducedHolders
Q1 2024417,888$12.9M<0.1%−506,977−54.8%ReducedHolders
Q4 2023924,865$37.3M0.1%−416,378−31.0%ReducedHolders
Q3 20231,341,243$35.4M0.1%−291,743−17.9%ReducedHolders
Q2 20231,632,986$28.1M<0.1%−599,035−26.8%ReducedHolders
Q1 20232,232,021$37.0M0.1%−468,803−17.4%ReducedHolders
Q4 20222,700,824$20.6M<0.1%+342,755+14.5%AddedHolders
Q3 20222,358,069$23.4M<0.1%−90,390−3.7%ReducedHolders
Q2 20222,448,459$22.2M<0.1%−47,569−1.9%ReducedHolders
Q1 20222,496,028$25.3M<0.1%+1,209,939+94.1%AddedHolders
Q4 20211,286,089$21.5M<0.1%+1,119,497+672.0%AddedHolders
Q3 2021166,592$7.81M<0.1%−2,142−1.3%ReducedHolders
Q2 2021168,734$10.3M<0.1%+142,975+555.0%AddedHolders
Q1 202125,759$1.59M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.